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Abstract
Toxin-antitoxin (TA) systems are widespread among the plasmids and genomes of bacteria and archaea. This work reports
the first description of a functional TA system in Streptomyces that is identical in two species routinely used in the
laboratory: Streptomyces lividans and S. coelicolor. The described system belongs to the YefM/YoeB family and has a
considerable similarity to Escherichia coli YefM/YoeB (about 53% identity and 73% similarity). Lethal effect of the S. lividans
putative toxin (YoeBsl) was observed when expressed alone in E. coli SC36 (MG1655 DyefM-yoeB). However, no toxicity was
obtained when co-expression of the antitoxin and toxin (YefM/YoeBsl) was carried out. The toxic effect was also observed
when the yoeBsl was cloned in multicopy in the wild-type S. lividans or in a single copy in a S. lividans mutant, in which this
TA system had been deleted. The S. lividans YefM/YoeBsl complex, purified from E. coli, binds with high affinity to its own
promoter region but not to other three random selected promoters from Streptomyces. In vivo experiments demonstrated
that the expression of yoeBsl in E. coli blocks translation initiation processing mRNA at three bases downstream of the
initiation codon after 2 minutes of induction. These results indicate that the mechanism of action is identical to that of YoeB
from E. coli.
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Introduction
Toxin-antitoxin (TA) modules were originally identified as
plasmid maintenance or stability modules [1]. Later, such modules
were described as being very abundant in the genome of different
bacteria and archaea [2]. The role of these systems in the genome
is not clear; however, they have been reported to act as guardians
against DNA lost, serve as protection against invading DNA, and
involved in stress management either through programmed cell
death of a wide part of the population or contributing to the origin
of persister cells by inducing a dormant stage (stasis) that permit to
the cells to be highly tolerant to antibiotics [2,3].
Regarding the nature and action of the antitoxin, three types of
TA systems -class I, II, and III- have been described, class II being
the most abundant [4]. This class II of TA systems comprises two
small proteins, which act as a toxin-antitoxin complex in which the
toxin is inactivated by the antitoxin. The efficiency of these TA
systems depends on a difference in lifespan between the toxin and
antitoxin. While toxins are highly resistant to proteases, the
lifespan of antitoxin is shorter than the toxin owing to their high
susceptibility to protease activity. When the toxins are released
from the complex they produce their toxic effect through different
modes of action: acting as endoribonucleases, poisoning DNA
gyrase, inhibiting translation initiation or elongation or inducing
defects in cell wall synthesis [5,6]. Mainly, antitoxin counteracts
toxin activity by direct protein-protein interaction and also by
repressing transcription of the TA system through interaction with
palindromic sequences within the promoters. In this regulation of
their own promoter, toxins act as co-repressors, cooperatively
improving the DNA interaction. However, in the case of three-
component systems, antitoxin and DNA-binding activities are
encoded by two separated proteins [7,8,9].
TA systems have been studied mostly in Gram-negative bacteria
and, as usual, the organism studied in greatest depth is Escherichia
coli, in which at least 33 TA systems have been identified [10]. The
availability of a large number of genomes and the use of
bioinformatics tools have permitted the identification of a huge
number of putative TA systems in different microorganisms [11];
these have been completed in later studies and are accessible at
some servers such as: http://genoweb.univ-rennes1.fr/duals/
RASTA-Bacteria/ [12] and http://bioinfo-mml.sjtu.edu.cn/
TADB/ [13]. In regards to the structure of these proteins and
their activities, up to 12 toxin super-families and 20 antitoxin
super-families have been described and validated [9].
Our work started after the prediction of the existence of three
putative TA loci in the chromosome of Streptomyces coelicolor by
Pandey and Gerdes [11]. The present study is the first
experimental demonstration of the functionality of one of these
systems in S. lividans, and in S. coelicolor. The orthologous genes of
both organisms are identical, even in the promoter region, and
correspond to an operon that encodes the proteins identified under
the NCBI accession numbers ZP_06531415 and ZP_06531416 in
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SCOs2235/2236 from S. coelicolor. The system shows considerable
similarity to the YefM/YoeB system from E. coli, composed of the
protein YefM, which is an unstable antitoxin, and YoeB, which is
a stable toxin. E. coli YefM/yoeB form a heterotrimer (toxin:anti-
toxin 1:2) that inactivates the effect of the toxin [14]. Free toxin
acts by inhibiting translation initiation by associating directly with
the 50S ribosome subunit. In particular, it interacts with the A site,
originating mRNA cleavage and releasing the 39-end portion of
the mRNA from the ribosome [15].
Here we show that the introduction of the S. lividans toxin gene
(yoeBsl) in multicopy plasmids is toxic in E. coli SC36, in S. lividans,
and in S. coelicolor wild types strains and that its effect is reversed by
the co-expression of the antitoxin gene (yefMsl). S. coelicolor (DyefM/
YoeB) and S. lividans (DyefM/yoeB) null mutants have greater
sensitivity to the toxin expression than the wild-type strains and the
expression of a single copy of the corresponding gene is lethal.
Purification of the S. lividans antitoxin (YefMsl), toxin (YoeBsl), and
the TA complex (YefM/YoeBsl) allowed us to observe the specific
binding of this complex to the promoter region of the bicistronic
operon. In vivo experiments demonstrated that the toxin YoeBsl
acts inhibiting translation initiation by processing the mRNA at
three bases downstream of the initiation codon. The data reported
constitute the first experimental demonstration of the functionality
of a TA system in Streptomyces.
Results
Identification of TA systems in Streptomyces
Three TA loci were proposed in the chromosome of S. coelicolor
by sequence similarity [11]. One of them was classified as a relBE
type (GI: 21220706, 21220707) and the other two as phd/doc
type(s) (GI: 21218953, 21218954 and GI: 21224247, 21224248).
Here we experimentally characterized the first one (GI: 21220706,
21220707), encoded by the SCOs2235/2236 (these were named
yefMsc and yoeBsc, respectively). Identical gene sequences were
present in S. lividans, and they were designated yefMsl and yoeBsl
respectively. The yefMsl gene encodes the putative antitoxin
YefMsl (orthologous to YefMsc) and yoeBsl encodes the putative
YoeBsl toxin (orthologous to YoeBsc). This corresponds to an
operon that encodes the proteins identified under the NCBI
accession numbers ZP_06531415 and ZP_06531416 respectively.
Although the system yefMsc-yoeBsc was first recognized as a
relBE system, actual studies permit classify it as a hybrid system on
which YefMsc antitoxin shows more sequence homology with Phd
superfamily and the YoeBsc toxin belongs to the ParE/RelE toxin
superfamily. These hybrid associations are more common than
originally thought [9].
This locus is a bicistronic operon in which the upstream gene
encodes the putative antitoxin of 9.7 kDa with a pI of 4.57 and the
downstream one encodes the putative toxin of 9.9 kDa with a pI of
9.4. The last codon of the antitoxin gene overlaps with the first GTG
codon of the toxin (Fig. 1A). Both proteins share clear identity with
the YefMand YoeBproteinsfromE.coli(52%and 54%respectively)
(Fig. 1B) and with other relBE-type TA systems from different
microorganisms (data not shown). Upstream of the antitoxin gene,
there is an intergenic region of 173 pb that may acts as the promoter
of this system and it is identical in S. coelicolor and in S. lividans.
Analysis of this region with BPROM identified the putative-35 and -
10 boxes and a putative Shine-Dalgarno region (Fig. 1C).
OverexpressionoftheS. lividans toxingeneislethalinE. coli
The effect of the overexpression of yoeBsl was studied in E. coli
SC36 (DyefM-yoeB strain). PCR amplification of the yoeBsl gene
from the S. lividans genome and cloning into the pFUS2 plasmid
[16] provided the pFUS2-tox plasmid (Materials and Methods). In
this plasmid, the S. lividans toxin gene is under the control of the
arabinose-inducible PBAD promoter. Plasmid pFUS2-tox was
transferred into E. coli SC36, and cell growth was tested in the
presence of glucose or arabinose (repressing and inducing
conditions respectively). Normal cell growth was observed when
the E. coli (pFUS2-tox) cells were cultivated in the presence of
glucose. However, a strong reduction in cell growth was observed
when the liquid cultures were shifted to an arabinose-containing
medium (Fig. 2A). A reduction in the number of viable cells was
also observed when the different cultures were inoculated on LB
plates one hour after protein induction (Fig. 2B). In contrast, the
growth of E. coli strains containing pFUS2 (empty plasmid) or
pFUS2-TA (which carries the complete operon under the control
of the PBAD promoter) was normal and fairly similar in both liquid
glucose- and arabinose-containing medium (Fig. 2A) and also on
LB plates (Fig. 2B). The same result was obtained when a carboxy-
His-tagged YoeBsl (pFUS2-ToxHis6) was produced in E. coli (data
not shown).
These results demonstrated that the protein encoded by the
yoeBsl gene is a potent toxin against E. coli cells and that the protein
encoded by yefMsl can counteract this toxicity when it is expressed
at the same time. Therefore, these observations indicate that this
operon works as a typical TA locus in E. coli.
Overexpression of the toxin gene is lethal in S. lividans
The effect of overexpression of the putative toxin encoding gene
yoeBsl was also studied by transforming wild-type S. lividans
protoplasts with a multicopy plasmid (a pN702Gem3 derivative)
that expressed yoeBsl gene under the control of the strong
Streptomyces promoter xysAp [17]. The number of transformants
obtained in the S. lividans wild-type strain with the multicopy
plasmid pN702Gem3-Tox was very low in comparison with the
number of transformants obtained when the same protoplasts were
transformed with an identical amount of the empty plasmid
(pN702Gem3) or with plasmid pN702Gem3-TA, bearing the
complete operon. Also, the colonies obtained with the plasmid
pN702Gem3-Tox were smaller in size indicating the toxicity of the
YoeBsl protein due to its overexpression in S. lividans (Fig. 3A). In
addition, the few colonies carrying the plasmid pN702Gem3-Tox
hardly grew when were reinoculated on patches on plates of R2YE
medium supplemented with 1% xylose (xysAp-inducer) suggesting
that the accumulation of the toxin in these cells make them non
viable (Fig. 3B). However, when S. lividans wild type protoplasts
were transformed with an integrative plasmid pKC796-Tox (a
pKC796 derivative that carries the yoeBsl gene under the control of
the same promoter (xysAp) [17]) the number of colonies was similar
to that obtained with the pKC796 empty plasmid or with the
pKC796 derivative containing the complete operon (pKC796-TA)
(Fig. 3C).
These results indicated that the toxicity of YoeBsl seemed to
depend on the amount of protein accumulated in the cell and
suggested that the expression of the endogenous single copy of the
antitoxin encoding yefMsl gene in the genome could counteract the
toxic effect of an extra copy introduced with pKC796-Tox, but not
the higher amount originated by the multicopy plasmid
pN702Gem3-Tox.
To test this hypothesis, a deletion of the yefM/yoeBsl operon was
performed in S. lividans by means of REDIRECT technology (see
Materials and Methods) and the resulting mutant (DyefM/yoeBsl)
was used as a receptor for plasmids pKC796-Tox and the
corresponding empty vector. The integration of a single copy of
yoeBsl in this DTA strain (plasmid pKC796-Tox) was lethal and no
YefM/YoeB Toxin-Antitoxin System in Streptomyces
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obtained with the control plasmids was similar to that obtained
in the wild-type strain (Figure 3D). However, when the S. lividans
DyefM/yoeBsl null mutant was transformed with a plasmid
containing the antitoxin gene and then the yoeBsl gene was
integrated in the genome with pKC796-Tox the number of
colonies obtained was similar to that obtained with control
plasmids (pKC796 and pKC796-TA). This assay demonstrates
that the inhibition of colony formation induced by a single copy of
the toxin is counteracted by the expression of the antitoxin gene
(Figure 3E and 3F).
The same experiments were carried out with a DyefM/yoeBsc
mutant of S. coelicolor, obtained also along this work, and identical
results were obtained (data not shown).
All these results demonstrate that in fact, this TA system works
as a typical TA system in Streptomyces.
The S. lividans Toxin-Antitoxin complex interacts with its
TA promoter
The binding of toxin-antitoxin complexes to their promoters is
the main way of regulation of the TA operon [18]. To study this,
the yefMsl gene or the complete yefM/yoeBsl operon, were cloned in
the E. coli expression vector pET22b under the control of the T7
promoter, obtaining pET22b-Anti and pET22b-TA respectively
(Materials and Methods). These plasmids were introduced into E.
coli BL21 (DE3) cells, and the antitoxin and the antitoxin-toxin
complexes were purified. The toxin protein alone was purified
from the antitoxin-toxin complexes as indicated in materials and
methods. EMSA assays were used to analyze the interactions of
Streptomyces TA complexes with the 173 bp double-stranded DNA
corresponding to the intergenic region upstream of the antitoxin
gene of S. lividans. The purified toxin-antitoxin complexes
produced a single retardation band in the migration of the DNA
corresponding to the TA promoter at a concentration of 1 mM
(Figure 4A). However, no band-shift was detected, under the used
conditions, when only the antitoxin (concentrations of 2–8 mM) or
the toxin (concentrations of 1–4 mM) was used to bind the
promoter (Figure 4B and 4C respectively). EMSA assays with the
in vitro reconstituted YefM-His6/YoeB-His6sl complex were
performed at different antitoxin/toxin ratios, and this permitted
us to observe that the best ratio for DNA retardation was 2:1
(Figure 4D). Two retardation bands were observed, one more
intense than the other, and none of them migrated to the same
level as the retardation band obtained with the natural-antitoxin-
toxin complex purified from E. coli cells (Figure 4D lanes 4, 5, 6
and 7 versus lane 8) (see discussion).
Figure 1. A) Schematic representation of the S. lividans Antitoxin-Toxin bicistronic operon. The overlap between the two genes is shown.
The stop codon of the antitoxin and the start codon of the toxin are shown in bold. B) Clustal alignment of the predicted amino acid sequence of the
putative S. lividans antitoxin (YefMsl) with E. coli YefM (YefMec) and the putative S. lividans toxin (YoeBsl) with E. coli YoeB (YoeBec). Identical amino
acids are boxed in black and conservative amino acid substitutions are boxed in grey. Semi-conservative substitutions are shown with one dot. C)
DNA sequence of the putative promoter of the S. lividans TA system. The putative -35 and -10 regions as well as the ribosome-binding site (SD) are
underlined.
doi:10.1371/journal.pone.0032977.g001
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promoters, randomly selected (Materials and Methods), were used
(Figure 4E). Thus, the interaction of the YefM/YoeBsl complex
with the DNA of its promoter was specific and was correlated with
the typical regulation of other TA systems described in different
organisms.
Purified YoeBsl inhibits protein synthesis on a Cell-free
system
The effect of purified YoeB-His6sl on cell-free protein synthesis
was examined over MazG. The synthesis of MazG protein from
plasmid pET11a-mazG was performed at 37uC for 30 min in the
absence and presence of YoeB-His6sl using an E. coli T7 S30
extract system (Promega) (Fig. 5A). MazG synthesis was almost
completely blocked at YoeB-His6sl concentrations of 0.5 mMo r
above. Similar inhibition was observed when purified YoeBec was
added [15]. We then tested the effect of YefM-His6sl antitoxin on
the YoeBsl-mediated inhibition of MazG synthesis and found that
the addition of YefM-His6sl recovered MazG synthesis (Fig. 5A,
lane 6).
YoeBsl cleavages ompA mRNA in vivo
We next attempted to identify the cleavage sites of the ompA
mRNA by primer extension experiments. For this purpose, total
RNA was extracted from E. coli BL21(DE3) cells harboring
pFUS2-Tox at different time intervals following induction of yoeBsl
expression. The primer extension analyses of the ompA mRNA
demonstrated that the distinct major bands exhibiting the specific
cleavage sites in the mRNA appeared as early as 2 min after
YoeBsl induction (Fig. 5B, lane 2). The major bands resulted from
the cleavage of the mRNA at three bases downstream of the
initiation codon, AUG, and most notably no other bands were
observed in the regions between the 59-end of the mRNA and the
initiation codon indicating that YoeBsl may function only when it
associates with the ribosomal translation machinary. These data
showed that YoeBsl might primarily inhibit translation initiation,
as shown with E. coli YoeBec [15].
Discussion
The putative roles of TA systems located in genomes are not
clear. Some of them have been implicated in programmed cell
death under different stress conditions, such as MazE/F from E.
coli [19], (and references therein) or in the fruiting body formation
of Myxococcus xanthus, where a MazF homologue is involved in the
regulation cascade controlled by the MrpC regulator [20]. Several
models have been proposed to explain the persistence of these
systems in genomes, where they may contribute to the stability of
the genomes and plasmids, and might act as anti-addiction
modules by preventing post-segregational killing [2,19].
The abundance of these systems in different organisms has been
detected thanks to the massive sequencing and the use of
bioinformatics tools, which have shown that TA systems may
represent 1.5% of the coding sequences in certain free-living
Figure 2. Effect of the overproduction of YoeBsl and YefM/YoeBsl complexes in E. coli SC36 (MG1655 DyefM-yoeB). A) Cells
transformed with control plasmid (pFUS2), with the plasmid carrying yoeBsl (pFUS2-Tox), or with the plasmid carrying the yefM/yoeBsl (pFUS2-TA)
were grown in liquid LB medium to mid-logarithmic phase. At this time (time zero), 0.2% glucose (diamond) was added to one half of each culture
and 0.2% arabinose (square) to the other half. Cell growth was monitored measuring the OD600 of the cultures at different times. The means and
standard deviation of three different experiments is presented. B) 5 ml of serial dilutions of the different cultures, taken one hour after protein
induction, were inoculated in LB plates and incubated overnight at 37uC. The upper plates were inoculated with cells from media with glucose
(repression), and the lower plates were inoculated with cells from media with arabinose (induction).
doi:10.1371/journal.pone.0032977.g002
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(DyefM/yoeBsl) mutant (D, E, F). A) R2YE agar plates showing the colonies obtained in transformations with the same DNA amount of empty
multicopy vector (pN702Gem3), the plasmid carrying the yoeBsl gene (pN702Gem3-Tox) or the plasmid containing yefM/yoeBsl genes (pN702Gem3-
TA). B) Viability of the colonies obtained in the transformation after streaking them onto R2YE media containing 1% xylose (inducing conditions of
the xysAp promoter). C) R2YE agar plates showing the colonies resulted from the transformation of the S. lividans wild type strain with the same DNA
amount of empty integrative vector (pKC796) or with this plasmid carrying the yoeBsl gene (pKC796-Tox) or the plasmid carrying the yefM/yoeBsl
genes (pKC796-TA). D) As in C, but using the S. lividans DTA (DyefM/yoeBsl) mutant as host. E and F) Effect of coexpression of YefMsl and YoeBsl, from
different compatible plasmids, in S. lividans DyefM/yoeBsl mutant. Protoplasts of S. lividans DyefM/yoeBsl mutant carrying the empty multicopy vector
pGM160 (E) or the plasmid pGM160-yefMsl (F) were transformed with the same amount of integrative plasmid pKC796 or its derivatives pKC796-Tox
or pKC796-TA and inoculated in R2YE plates. The presence of pGM160-yefMsl in this strain eliminates the lethality originated by pKC796-Tox.
doi:10.1371/journal.pone.0032977.g003
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some obligate intracellular species such as Ricketsia bellii OSU 85–
389, where they represent 2.2% of its ORFs. However, TA
systems are absent in other obligate intracellular species such as
Buchnera aphicola or in different species of Chlamydia, suggesting their
loss due to genome reduction [9]. Horizontal gene transfer
associated with mobile genetic elements has been proposed to
explain the presence of highly conserved orthologous in phyloge-
netically different organisms [2].
Only three TA systems had been proposed in S. coelicolor [11]
when we began this work. However, recently, up to 24 TAs have
been proposed [13], although in no case has their functionality
been demonstrated. Here, the first study of the functionality of one
of these putative TA systems of Streptomyces is described,
corresponding to the SCOs2235/2236 of S. coelicolor and to the
ZP_06531415/ZP_06531416 sequences of S. lividans. This system
is similar to the YefM/YoeB system from E. coli, sharing about
53% identity and 73% similarity in both proteins. Even, two
arginine residues highly conserved in the E. coli YefM orthologs
(R10 and R31) [5] that are important in the direct interaction with
the operator sequence are conserved in Streptomyces antitoxin in
similar positions (R9 and R31). This observation suggests a
putative horizontal transfer of this TA system between the
ancestors of both organisms due that other randomly taken S.
coelicolor and S. lividans genes from primary metabolism share only
about 20–34% identity with their E. coli orthologous genes.
BLAST analysis of the proteins studied (YefM/YoeBsl) against
16 species of Streptomyces sequenced by the Broad Institute (http://
www.broadinstitute.org/annotation/genome/streptomyces_group/
GenomesIndex.html) confirmed the presence of YefM/YoeBsl
Figure 4. EMSA assays of the 173 bp intergenic region upstream of the yefM/yoeBsl operon with different proteins: (A) purified
complex YefM/YoeB-His6sl (0, 1, 2 and 5 mM); (B) purified YefM-His6sl (0, 2, 4 and 8 mM); (C) Purified YoeB-His6sl (0, 1, 2, and 4 mM).
D) EMSA assays with in vitro reconstituted YefM-His6/YoeB-His6sl complexes. The absence or presence of YoeB-His6sl, and/or YefM-His6sl is indicated
by 2/+ respectively. 2 mM of YoeB-His6sl were used (lanes 3–7), and mixed with increasing amounts (1, 2, 4 and 8 mM) of YefM-His6sl (lanes 4–7). 1 mM
of natural purified YefM/YoeB-His6sl complex was used as a control (lane 8). E) EMSA assays of different promoters from S. coelicolor (the SCO number
is indicated) with (+) or without (2)1mM of the purified complex YefM/YoeB-His6 sl.
doi:10.1371/journal.pone.0032977.g004
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species. Surprisingly, some orthologous genes from different
Streptomyces species have lower identity with the system studied than
the YefM/YoeB system from E. coli. It is also of interest that two
strains -S. hygroscopicus ACCT53653 and Streptomyces sp. C- each have
two YefM/YoeB orthologous systems in their genome that are fairly
similar (90% and 79% similarity, respectively) to the TA studied
here, suggesting a putative total or partial duplication of this TA
system. Interestingly, one of these putative TA systems in S.
hygroscopicus ACCT53652 has a putative toxin (ZP_07297953) with
only 52 amino acids, while S. coelicolor and S. lividans toxin has 84
amino acids.
The organization of the yefM/yoeBsl operon is similar to other
bacterial TA modules in which the first gene encodes the antitoxin
and overlaps the toxin gene in three nucleotides, supporting the
existence of translational coupling between both genes. Upstream
of the antitoxin gene, there is an intergenic region of 173
nucleotides that may act as a bidirectional promoter region and
that is identical in S. coelicolor and S. lividans. This promoter has the
TA operon on one side and the glnE gene that encodes the
glutamate-ammonia-ligase adenylyltransferase on the other.
EMSA assays demonstrated the high capacity of the YefM/
YoeBsl complexes to bind this intergenic region. A divergent
promoter is also present upstream of the E. coli yefM/yoeB system,
but in this case the hisL gene is present on the other side of the
promoter. Long and short palindromes with the core motif 5-
TGTACA-3 are present in the E. coli promoter and have been
described as the binding site for the YefM/YoeBec complexes
[5,21]. In the Streptomyces yefM/yoeB promoter there is a
palindromic sequence 59-TCGTACGA-39 overlapping the puta-
tive -10 region and a downstream almost perfect palindrome 59-
TGTACC-39 separated by a centre-to-centre distance of 12 bp
that is the same distance between the palindromic sequences
described in E. coli. Preliminary results indicate that these
Figure 5. Effect of YoeBsl on protein synthesis in a cell-free system and Primer extension analysis of YoeBsl cleavage sites in the
ompA mRNA in vivo. A) MazG protein synthesis was carried out using E. coli T7 S30 extract system for circular DNA (Promega) with pET11a-mazG.
Lane 1, without YoeB-His6sl; lanes 2 to 5, 0.1, 0.2, 0.5 and 1 mM YoeB-His6sl were added, respectively; lane 6, 1 mM YoeB-His6sl plus 1 mM YefM-His6sl;
and lane 7, 1 mM YefM-His6sl was added. B) Total RNA was prepared from E. coli BL21 cells harboring pFUS2-Tox at indicated time points before and
after the induction of yoeBsl expression. The major cleavage site is indicated by an arrowhead on the right side of the gel. The sequence of the major
cleavage site in the ompA mRNA is also shown on the right side of the gel. The sequence ladder for ompA was obtained using pCRH2.1-TOPO-ompA
as template. The full-length RNA bands (FL) are indicated with an arrow.
doi:10.1371/journal.pone.0032977.g005
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complex (data not shown).
Deletion of the complete yefM/yoeB operon from S. coelicolor and
from S. lividans originated strains with a slight retardation on
sporulation when cultured on MSA medium but no other
phenotypes were obviously different from the corresponding
wild-type strains (data not shown). This ‘‘no-effect’’ has been
described for simultaneous deletions of several TA systems from E.
coli [22]. However, more detailed studies of these E. coli strains
have later revealed differences in the capacity of this TA-deleted
strain to produce biofilm. In particular, those authors observed
that the E. coli antitoxin YefM clearly increased biofilm formation
through an as yet unknown mechanism [23]. These results point to
the need for a large number of tests aimed at identifying the true
role of the Streptomyces TAs under laboratory conditions.
Overproduction of YoeBsl in the DyefM/yoeB E. coli SC36 strain
originated a strong reduction in cell viability that was reversed by
the co-expression of the YefMsl antitoxin. A similar lethal effect
was observed when only one copy of the toxin gene was integrated
into the chromosome of the S. lividans,o rS. coelicolor DyefM/yoeB
mutants, where no transformants were obtained. However, this
toxic effect was not observed in S. lividans or S. coelicolor wild-type
strains when an extra copy of the toxin gene was integrated in the
genome, and the toxic effect was only detected when a multicopy
plasmid was used to express the toxin gene. These results suggest
that in these strains the endogenous antitoxin was able to block the
lethal effect of an extra copy of the toxin gene but not enough
when more copies of the gene were present.
In vitro experiments demonstrated that the His-tagged YoeB-
His6sl and YefM-His6sl proteins are active in experiments of
inhibition of protein synthesis. However, EMSA assays, demon-
strated that in vitro reconstituted YefM-His6/YoeB-His6sl complex
produced two retarded bands with the cognate promoter instead
of one as it was obtained with the S. lividans TA complex purified
from E. coli. These results suggest a different conformation of the
reconstituted complex maybe due to the extra His6-tag present in
the antitoxin carboxy terminus. Similar results have been
described previously with the YefM/YoeB proteins from E. coli
[21].
In vivo experiments with the protein YoeBsl demonstrated that
its activity is identical to YoeBec processing ompA mRNA mainly at
three bases downstream of the initiation codon. However, unlike
YoeBec processing, where a significant amount of full-lengh ompA
mRNA remains even 30 min after induction of the E. coli toxin
[15], most of the full-lengh mRNA disappears after only two
minutes of yoeBsl expression. This result suggests a higher mRNA
processing activity of the YoeBsl compared to YoeBec.
Materials and Methods
Bacterial strains and growth conditions
The E. coli strains used were as follows: DH5a [24] for the
cloning and isolation of plasmids; BL21 (DE3) (Stratagene) to
express and purify proteins, and SC36 (MG1655 DyefM-yoeB) [25]
to evaluate toxin toxicity. E.coli BW25113 (pIJ790), ET12567
(pUZ8002), and DH5a (pBT30) were used for gene replacement
[26]. All strains were grown in Luria-Bertani (LB) liquid broth or
on LB agar. All manipulations in E. coli were performed following
standard procedures [24].
S. coelicolor M145, S. lividans 1326 and derivatives were grown on
solid R2YE medium for transformation, on MSA medium for
sporulation [27], and in liquid YES medium (1% yeast extract
10.3% sucrose [pH 7.2] supplemented with 0.5% glucose, 5 mM
MgCl2 and 0.5% glycine) for collecting cells to make protoplasts.
Liquid cultures were carried out in baffled flasks at 28uC and
200 rpm. All manipulations in Streptomyces were done as indicated
by Kieser [27].
Deletion of the yefM/yoeB operon in S. coelicolor and in S.
lividans
REDIRECT PCR-targeting technology [26] was used to
replace the genes of the entire yefM/yoeB operon to an apramycin
(aac(3)IV gene) resistance cassette in S. coelicolor M145 and in S.
lividans 1326. Mutagenic cassettes were flanked by the recognition
sequence of yeast Flipase (FRT) and contained the oriT (FRT-
aac(3)IV-oriT-FRT) conjugation transfer origin and were amplified
with primers LS-013 and LS-014 (Table 1), using plasmid pIJ773
as template [26]. The cassettes generated were introduced into E.
coli BW25113 (pIJ790), harboring the cosmid 7B11, and
preinduced for lRed functions by the addition of arabinose to
obtain a TA-disrupted version of the mutant cosmid. The
disrupted cosmid, confirmed by restriction analysis, was isolated
and transferred from E. coli ET12567 (pUZ8002) to S. coelicolor
M145 and to S. lividans by conjugation. Exconjugants were selected
on MSA medium containing apramycin (50 mg/mL), and the
double crossover products were identified by their sensitivity to
kanamycin (50 mg/mL). The antibiotic-resistant marker and the
oriT region were eliminated in two steps. In the first, the
corresponding disrupted cosmid was introduced into the E. coli
DH5a (pBT30) strain (harboring the flipase gene, FLP), in which
the recombination between both FRT mutagenesis cassette-
flanking regions takes place. In this new cosmid, only 81 base
pairs (SCAR) in-frame with the adjacent ORFs remained. Then,
the SCAR cosmid was transferred to the Streptomyces apramycin
resistance mutant strains by protoplast transformation, first
selecting neomycin resistance clones (unique recombination), and
then the apramycin- and neomycin-sensitive strains (double
recombination). PCR assays confirmed the correct recombination
in the new Streptomyces mutant strains.
Toxicity evaluation in E. coli
yoeBsl DNA was amplified by PCR from S. lividans 1326 genomic
DNA using primers LS-008 and LS-009 (Table 1). The resulting
fragment was digested with NdeI and XhoI and ligated into
plasmid pXHis1 [28] (Table 2) digested with the same enzymes to
obtain plasmid pXHis-Tox, which was used as an intermediate
plasmid. Plasmid pFUS2-Tox was obtained by digesting pXHis-
Tox with NdeI and HindIII and ligated into plasmid pFUS2 [16]
(Table 2), digested with the same enzymes. This construction
placed the ORF of the putative toxin gene under the control of the
arabinose-inducible promoter PBAD and had the fdt transcriptional
terminator at the 39 end.
A similar strategy was used to amplify the genes of the complete
operon (yefM/yoeBsl), using primers LS-005 and LS-009 (Table 1).
The resulting PCR fragment was digested with NdeI and XhoI
and ligated into plasmid pXHis1 digested with the same enzymes
to obtain plasmid pXHis-TA, which was used as an intermediate
plasmid. Plasmid pFUS2-TA was obtained by digesting pXHis-TA
with NdeI and HindIII and ligated into plasmid pFUS2 digested
with the same enzymes. This construction placed the complete
operon under the control of the arabinose-inducible promoter
PBAD and had the fdt transcriptional terminator.
E. coli SC36 cells transformed with pFUS2 (control), pFUS2-
Tox or pFUS2-TA were grown at 37uC on LB broth
supplemented with 50 mg/mL of kanamycin to an OD600 of
0.5–0.8 and the cultures were divided into two parts. One half of
each culture was grown in the presence of 0.2% glucose
(repression conditions) and the other half in the presence of
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Plasmid Characteristics Reference
pIJ773 pBluescript SK derivative containing the Apramycin resistance cassette. [26]
pXHis1 pBluescript SK derivative. Ampicillin resistance. The xysA promoter from
S. halstedii controls xys1D expression.
[28]
pXHis-Tox pXHis1 derivative. The xysA promoter from S. halstedii controls toxin expression. This work
pXHis-TA pXHis1 derivative. The xysA promoter from S. halstedii controls TA expression. This work
pFUS2 E. coli expression vector. Kanamycin resistance. PBAD promoter. [16]
pFUS2-Tox pFUS2 derivative. PBAD promoter controls toxin expression. This work
pFUS2-TA pFUS2 derivative. PBAD promoter controls TA expression. This work
pN702GEM3 E.coli/Streptomyces shuttle vector. Neomycin resistance. High-copy number. [29]
pN702Gem3-Tox pN702GEM3 derivative. The xysA promoter from S. halstedii controls toxin expression. This work
pN702Gem3-TA pN702GEM3 derivative. The xysA promoter from S. halstedii controls TA expression. This work
pKC796 E.coli/Streptomyces shuttle vector. Apramycin resistance. Integrative plasmid. [30]
pKC796-Tox pKC796 derivative. The xysA promoter from S. halstedii controls toxin expression. This work
pKC796-TA pKC796 derivative. The xysA promoter from S. halstedii controls TA expression. This work
pET22b E. coli expression vector. Ampicillin resistance. Novagen
pET22b-Anti pET22b derivative. Expressing antitoxin gene with a His6 tag at the carboxy terminal. This work
pET22b-TA pET22b derivative. Expressing the TA operon. In this construction the toxin gene has a
His6 tag at the carboxy terminal.
This work
pGM160 E.coli/Streptomyces shuttle vector. Thiostrepton and gentamicin resistance. [31]
pGM160-YefMsl pGM160 derivate. The xysA promoter from S. halstedii controls YefMsl expression. This work
doi:10.1371/journal.pone.0032977.t002
Table 1. Oligonucleotides used.
Name Sequence 59-39 Use
LS-001 TTTTTTGAATTCTGTGCGGCTGCCCTTCCGCC Forward oligonucleotide to amplify the promoter of SCO1968.
The sequence recognized by EcoRI is underlined.
LS-002 TTTTTTCATATGCGTACTCCTCGCGTCGAACG Reverse oligonucleotide to amplify the promoter of SCO1968.
The sequence recognized by NdeI is underlined.
LS-005 TTTTTTCATATGTCCATCACCGCCAGCGAAG Forward oligonucleotide for cloning the TA operon into pXHis1
and pET22b. The sequence recognized by NdeI is underlined.
LS-008 TTTTTTCATATGAGGATCACTTTCACGTCCCAC Forward oligonucleotide for cloning the toxin gene into pXHis1.
The sequence recognized by NdeI is underlined.
LS-009 TTTTTTCTCGAGTCAGTAGTGGTAGCGCGCCTGG Reverse oligonucleotide for cloning the toxin gene and TA operon
into pXHis1. The sequence recognized by XhoI is underlined.
LS-013 CAGACTCGTACGATATCTTGTACCAGCCGAGGA-
AGGGAGGCACTGGTATGATTCCGGGGATCCGTC-
GACC
Forward oligonucleotide to obtain the mutagenic cassette. The
sequence matching the sequence of the disruption cassette is
underlined.
LS-014 GCTTCGGCTTTCGCCGGTCGCGGGTGTCGTGTC-
CGTACCGGCGGGTGTCATGTAGGCTGGAGCTG-
CTTC
Reverse oligonucleotide to obtain the mutagenic cassette.
The sequence matching the sequence of the disruption
cassette is underlined.
LS-019 TTTTTTGAATTCTCGGCCTCCTGTCGGGCTG Forward oligonucleotide to amplify TA promoter. The sequence
recognized by EcoRI is underlined.
LS-020 TTTTTTCATATGACCAGTGCCTCCCTTCCTCGG Reverse oligonucleotide to amplify TA promoter. The sequence
recognized by NdeI is underlined.
LS-021 TTTTTTCTCGAGGTAGTGGTAGCGCGCCTGGAC Reverse oligonucleotide for cloning the TA operon into pET22b. The
sequence recognized by XhoI is underlined.
LS-022 TTTTTTCTCGAGCGCCCGCTCCGCGTCCGGG Reverse oligonucleotide for cloning the antitoxin gene into pET22b.
The sequence recognized by XhoI is underlined.
AY-147 TAGAACACGGGTCCGACAGTCC Forward oligonucleotide to amplify the promoter of SCO1715.
AY-148 ATCGCTCCCTCGCAACCGATTC Reverse oligonucleotide to amplify the promoter of SCO1715.
AY-159 AGAGAGTATGTCCTAAATGTCCGG Forward oligonucleotide to amplify the promoter of SCO1480.
AY-160 GCCTACGTCACCTCGGATGTCG Reverse oligonucleotide to amplify the promoter of SCO1480.
doi:10.1371/journal.pone.0032977.t001
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monitored measuring the OD600. In addition, samples were
obtained 1 hour after induction and 5-ml drops of different
dilutions of cultures were spread onto the surface of LB agar
supplemented with 50 mg/mL of kanamycin. Plates were incubat-
ed overnight at 37uC.
Toxicity evaluation in Streptomyces
Multicopy plasmids were generated by cloning the yoeBsl toxin
encoding gene or the complete operon into plasmid pN702Gem3
[29] (Table 1). Plasmids pXHis-Tox and pXHis-TA were digested
with BglII and the DNA fragments containing the genes (Tox and
TA) were ligated with pN702Gem3 (Table 2) digested with the
same enzyme. The toxin and antitoxin-toxin genes of the resulting
plasmids, pN702Gem3-Tox and pN702Gem3-TA, are regulated
by the xylanase promoter xysAp [17]. All the constructions were
flanked by two transcriptional terminators.
Integrative Streptomyces plasmids, whose gene expression was
regulated by xysAp, were generated by cloning the corresponding
BglII/BglII fragments into the integrative plasmid pKC796 [30]
(Table 2). Plasmids pKC796-Tox and pKC796-TA were obtained
respectively.
Multicopy plasmid pGM160-YefMsl was generated by cloning
the antitoxin gene between BstBI and BamHI sites of pGM160
plasmid [31].
These plasmids were introduced by protoplast transformation
into S. lividans 1326 wt and DTA (lacking the chromosomal copy of
the system) and in S. coelicolor M145 wt and the corresponding
DTA mutant. Cell viability was estimated by checking their growth
in R2YE medium after incubation at 30uC.
Protein purification
S. lividans antitoxin-encoding DNA (yefMsl) and the DNA
corresponding to the TA operon (yefM/yoeBsl) were amplified by
PCR using primers LS005/LS022 and LS005/LS021 respectively
(Table 1) and cloned between the NdeI and XhoI sites in the pET-
22b vector (Novagen) to produce the antitoxin or toxin,
respectively, tagged C-terminally with a hexahistidine motif,
yielding pET22b-Anti and pET22b-TA respectively.
YefM-His6sl and the YefM/YoeB-His6sl complex were over-
produced in E. coli BL21 (DE3) transformed with the corre-
sponding plasmids. Five hours after induction with 1 mM IPTG,
cells were harvested at 50006g at 4uC for 10 min. The cell pellet
was resuspended in lysis buffer (5 mM Na2HPO4/NaH2PO4,
pH 7.5, 300 mM NaCl, 0.1%Triton X100, 5 mM imidazole),
and then sonicated and centrifuged for 30 min. at 100.0006g.
The supernatant was applied to a column containing 2 ml of
NTA-Ni resin (Qiagen). The column was washed three times with
5 mL of washing buffer 1 (5 mM Na2HPO4/NaH2PO4,p H7 . 5 ,
300 mM NaCl, 0.1% Triton X100, 20 mM imidazole) and twice
with 5 mL of washing buffer 2 (5 mM Na2HPO4/NaH2PO4,
pH 7.5, 300 mM NaCl, 0.1% Triton X100, 30 mM imidazole).
Tagged proteins were eluted 3 times with 0.5 mL of elution
buffer 1 (5 mM Na2HPO4/NaH2PO4, pH 7.5, 300 mM NaCl,
0.1% Triton X100, 250 mM imidazole) and twice with elution
buffer 2 (5 mM Na2HPO4/NaH2PO4, pH 7.5, 300 mM NaCl,
0.1% Triton X100, 1 M imidazole). Fractions containing the
highest concentrations of proteins were pooled and dialyzed with
D-Tube TM Dialyzer Maxi (Novagen) for 48 h against 2 L of
dialysis buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 10%
glycerol).
Purification of the toxin YoeB-His6sl was carried out in E. coli
BL21 (DE3) cells transformed with pET22b-TA that produces the
complex toxin-antitoxin. Protein production and purification were
done as described previously but the second wash of the NTA-Ni
resin, containing the complex antitoxin/toxin-His6, was performed
with 5 mM Na2HPO4/NaH2PO4, pH 7.5, 300 mM NaCl, 0.1
Triton X100%, 20 mM imidazole, 6 M guanidine hydrochloride
to denature the antitoxin protein YefMsl [21]. YoeB-His6sl was
then eluted as described above. Fractions containing the highest
concentrations of protein were pooled and dialyzed successively
for 2h against 500 mL of dialysis buffer containing 3 M, 2 M, and
1 M urea, followed by 24 h against 2 L of dialysis buffer without
urea. The concentration of TA complex was estimated assuming
an antitoxin:toxin ratio of 2:1), as has been described for E. coli
YefM-YoeB complexes [14]).
Electrophoretic mobility assays (EMSA)
The TA promoter was amplified by PCR from S. lividans 1326
genomic DNA using primers LS-019 and LS-020 (Table 1). The
resulting PCR fragment (196 bp) was used in the binding reactions
with the proteins. Different Streptomyces promoters unrelated to TA
systems were used as controls: namely, the promoter of SCO1968
(a putative secreted hydrolase, amplified with primers LS-001 and
LS-002, Table 1); SCO1715 (a putative homogentisate 1,2-
dioxygenase, amplified with primers AY-147 and AY-148,
Table 1), and SCO1480 a hypothetical protein, amplified with
primers AY-159 and AY-160, Table 1).
The binding reactions contained 150–200 ng of DNA, 10 mM
Tris-HCl, pH 7.5, 10 mM MgCl2, 100 mM NaCl, 10% glycerol,
2 mg of salmon sperm DNA, and different concentrations of the
proteins. The mixtures were incubated at 30uC for 20 min and
electrophoresed at 4uC on 5% native polyacrylamide gels in TBE
buffer 16(90 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 8.3).
DNA was visualized by gel staining with ethidium bromide (0.5 mg/
mL in TBE buffer). When YefM-His6sl and YoeB-His6sl were
added separately,thetwoproteinswerefirstincubatedatincubation
at 30uC for 20 min prior to the addition of DNA.
Assay of protein synthesis in vitro
Cell-free protein synthesis was performed with an E. coli T7 S30
Extract System for Circular DNA (Promega). The reaction
mixture was prepared as described in the manufacture’s protocol.
Then, different amounts of YoeB-His6sl and YefM-His6sl were
added in a final volume of 29 ml. The reaction was started by the
addition of pET11a-mazG plasmid DNA [15,32] and the mixture
was incubated for 30 min at 37uC. Proteins were precipitated with
acetone and analyzed by 15% SDS-PAGE. The dried gel was
followed by autoradiography.
Primer extension analysis in vivo
For primer extension analysis of mRNA cleavage sites in vivo,
total RNA was extracted from the E. coli BL21(DE3) cells
containing pFUS2-Tox at different time points after YoeBsl
induction. Primer extension was carried out as described
previously [33].
Sequence analysis
All constructions were sequenced in both strands using a Perkin
Elmer ABI Prism 377 DNA sequencer. In silico plasmids were obtained
with the Gene Construction Kit software (GCK, Textco). BPROM
software (http://linux1.softberry.com/berry.phtml) was used to search
for conserved sequences in the putative promoter of the TA system.
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